Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 1/2005

01-01-2005

Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy

Authors: Takahiro Yamasaki, Teruaki Kimura, Fumie Kurokawa, Kouji Aoyama, Tsuyoshi Ishikawa, Kunihiko Tajima, Yuichiro Yokoyama, Taro Takami, Kaoru Omori, Kotaro Kawaguchi, Masako Tsuchiya, Shuji Terai, Isao Sakaida, Kiwamu Okita

Published in: Journal of Gastroenterology | Issue 1/2005

Login to get access
Metadata
Title
Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy
Authors
Takahiro Yamasaki
Teruaki Kimura
Fumie Kurokawa
Kouji Aoyama
Tsuyoshi Ishikawa
Kunihiko Tajima
Yuichiro Yokoyama
Taro Takami
Kaoru Omori
Kotaro Kawaguchi
Masako Tsuchiya
Shuji Terai
Isao Sakaida
Kiwamu Okita
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 1/2005
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-004-1494-7

Other articles of this Issue 1/2005

Journal of Gastroenterology 1/2005 Go to the issue

Case report

Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature

OriginalPaper

Pulmonary blood transit time and impaired arterial oxygenation in patients with chronic liver disease

OriginalPaper

Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer

OriginalPaper

Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure

OriginalPaper

Defense mechanisms in inflammatory bowel disease

Editorial

Reflux or reflex in GERD-related asthma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits